OBJECTIVE: Our aim was to compare 2 Framingham vascular risk scores with a dementia risk score in relation to 10-year cognitive decline in late middle age. METHODS: Participants were men and women with mean age of 55.6 years at baseline, from the Whitehall II study, a longitudinal British cohort study. We compared the Framingham general cardiovascular disease risk score and the Framingham stroke risk score with the cardiovascular risk factors, aging and dementia (CAIDE) risk score that uses risk factors in midlife to estimate risk of late-life dementia. Cognitive tests included reasoning, memory, verbal fluency, vocabulary, and global cognition, assessed 3 times over 10 years. RESULTS: Higher cardiovascular disease risk and higher stroke risk were associated with greater cognitive decline in all tests except memory; higher dementia risk was associated with greater decline in reasoning, vocabulary, and global cognitive scores. Compared with the dementia risk score, cardiovascular and stroke risk scores showed slightly stronger associations with 10-year cognitive decline; these differences were statistically significant for semantic fluency and global cognitive scores. For example, cardiovascular disease risk was associated with -0.06 SD (95% confidence interval [CI] = -0.08, -0.05) decline in the global cognitive scores over 10 years whereas dementia risk was associated with -0.03 SD (95% CI = -0.04, -0.01) decline (difference in β coefficients = 0.03; 95% CI = 0.01, 0.05). CONCLUSIONS: The CAIDE dementia and Framingham risk scores predict cognitive decline in late middle age but the Framingham risk scores may have an advantage over the dementia risk score for use in primary prevention for assessing risk of cognitive decline and targeting of modifiable risk factors.
OBJECTIVE: Our aim was to compare 2 Framingham vascular risk scores with a dementia risk score in relation to 10-year cognitive decline in late middle age. METHODS:Participants were men and women with mean age of 55.6 years at baseline, from the Whitehall II study, a longitudinal British cohort study. We compared the Framingham general cardiovascular disease risk score and the Framingham stroke risk score with the cardiovascular risk factors, aging and dementia (CAIDE) risk score that uses risk factors in midlife to estimate risk of late-life dementia. Cognitive tests included reasoning, memory, verbal fluency, vocabulary, and global cognition, assessed 3 times over 10 years. RESULTS: Higher cardiovascular disease risk and higher stroke risk were associated with greater cognitive decline in all tests except memory; higher dementia risk was associated with greater decline in reasoning, vocabulary, and global cognitive scores. Compared with the dementia risk score, cardiovascular and stroke risk scores showed slightly stronger associations with 10-year cognitive decline; these differences were statistically significant for semantic fluency and global cognitive scores. For example, cardiovascular disease risk was associated with -0.06 SD (95% confidence interval [CI] = -0.08, -0.05) decline in the global cognitive scores over 10 years whereas dementia risk was associated with -0.03 SD (95% CI = -0.04, -0.01) decline (difference in β coefficients = 0.03; 95% CI = 0.01, 0.05). CONCLUSIONS: The CAIDE dementia and Framingham risk scores predict cognitive decline in late middle age but the Framingham risk scores may have an advantage over the dementia risk score for use in primary prevention for assessing risk of cognitive decline and targeting of modifiable risk factors.
Authors: F W Unverzagt; L A McClure; V G Wadley; N S Jenny; R C Go; M Cushman; B M Kissela; B J Kelley; R Kennedy; C S Moy; V Howard; G Howard Journal: Neurology Date: 2011-11-08 Impact factor: 9.910
Authors: Archana Singh-Manoux; Michael G Marmot; Maria Glymour; Séverine Sabia; Mika Kivimäki; Aline Dugravot Journal: Ann Neurol Date: 2011-05-11 Impact factor: 10.422
Authors: Yael D Reijmer; Esther van den Berg; Sanne van Sonsbeek; Jaqueline M Dekker; Giel Nijpels; Coen D A Stehouwer; L Jaap Kappelle; Jaap L Kappelle; G J Biessels Journal: Dement Geriatr Cogn Disord Date: 2011-02-18 Impact factor: 2.959
Authors: Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri Journal: Stroke Date: 2011-07-21 Impact factor: 7.914
Authors: Sara Kaffashian; Aline Dugravot; Hermann Nabi; G David Batty; Eric Brunner; Mika Kivimäki; Archana Singh-Manoux Journal: Eur Heart J Date: 2011-05-23 Impact factor: 29.983
Authors: Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen Journal: Neurology Date: 2014-03-28 Impact factor: 9.910
Authors: Andreea M Rawlings; A Richey Sharrett; Andrea L C Schneider; Josef Coresh; Marilyn Albert; David Couper; Michael Griswold; Rebecca F Gottesman; Lynne E Wagenknecht; B Gwen Windham; Elizabeth Selvin Journal: Ann Intern Med Date: 2014-12-02 Impact factor: 25.391
Authors: Cassandra L Brown; Annie Robitaille; Elizabeth M Zelinski; Roger A Dixon; Scott M Hofer; Andrea M Piccinin Journal: Psychol Aging Date: 2016-12
Authors: Rebecca F Gottesman; Andrea L C Schneider; Marilyn Albert; Alvaro Alonso; Karen Bandeen-Roche; Laura Coker; Josef Coresh; David Knopman; Melinda C Power; Andreea Rawlings; A Richey Sharrett; Lisa M Wruck; Thomas H Mosley Journal: JAMA Neurol Date: 2014-10 Impact factor: 18.302
Authors: Juho Tynkkynen; Jussi A Hernesniemi; Tiina Laatikainen; Aki S Havulinna; Jouko Sundvall; Jaana Leiviskä; Perttu Salo; Veikko Salomaa Journal: Age (Dordr) Date: 2016-09-23
Authors: D G Clark; A D Boan; C Sims-Robinson; R J Adams; E J Amella; A Benitez; D T Lackland; B Ovbiagele Journal: J Stroke Cerebrovasc Dis Date: 2018-08-01 Impact factor: 2.136